$AKRX Company News Speculators live by the sword, die

New Post Public Reply Private Reply Replies (0) Message Board

Sep 29, 2014 at 10:22 AM

$AKRX Company News

Speculators live by the sword, die by the sword 3:13 p.m. July 8, 2014 - The Trading Deck
Dow, Nasdaq nail the breakout point 10:36 a.m. June 27, 2014 - Michael Ashbaugh
From tiny Akorns grow mighty oaks? 11:03 a.m. Nov. 21, 2013 - The Trading Deck
Rail-Splitter's top small-cap bets are worth watching 12:34 p.m. Nov. 4, 2013 - Insider Monkey
Akorn to buy Hi-Tech for $640 million in cash 8:02 a.m. Aug. 27, 2013 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:20 p.m. July 23, 2012 - MarketWatch
Corrective bounce, or sustainable upturn? 10:59 a.m. June 6, 2012 - Michael Ashbaugh
Charting a bearish double top 12:11 p.m. May 15, 2012 - Michael Ashbaugh
Charting a bearish double top 11:45 a.m. May 15, 2012 - Michael Ashbaugh
Wednesday’s biggest gaining and declining stocks 6:02 p.m. March 7, 2012 - Sue Chang
Tuesday’s biggest gaining and declining stocks 5:23 p.m. March 6, 2012 - MarketWatch
Stocks to watch Tuesday: Nutrisystem, Jakks 8:00 a.m. March 6, 2012 - MarketWatch
S&P 500 scratches out three-year high 12:07 p.m. March 2, 2012 - Michael Ashbaugh
Stocks to watch Friday: LinkedIn, LeapFrog, Nuance 7:46 a.m. Feb. 10, 2012 - MarketWatch
S&P 500 vies for positive 2011 finish 12:09 p.m. Dec. 23, 2011 - Michael Ashbaugh
S&P, Nasdaq retest major support 12:51 p.m. Dec. 12, 2011 - Michael Ashbaugh
U.S. markets survive test of major support 10:57 a.m. Nov. 2, 2011 - Michael Ashbaugh
Akorn rallies on earnings, M&A deal 1:59 p.m. Aug. 2, 2011 - Val Brickates Kennedy
Drug stocks slip; Emergent rallies 1:28 p.m. May 26, 2011 - Val Brickates Kennedy
Drug stocks gain; Derma, Elan climb 3:51 p.m. May 25, 2011 - Val Brickates Kennedy

Meet 5 Top Stocks With Rising Earnings Estimates 7:02 a.m. Sept. 26, 2014 - Investors Business Daily
Progenics' Azedra Found Positive in Phase II Follow-Up Data - Analyst Blog 6:10 p.m. Sept. 23, 2014 - Zacks.com
Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog 4:55 p.m. Sept. 23, 2014 - Zacks.com
Acquisition-Hungry Akorn Sets Up Potential Buy Area 5:10 p.m. Sept. 22, 2014 - Investors Business Daily
Analysts Are Warming to These 5 Stocks 9:25 a.m. Sept. 22, 2014 - InvestorPlace.com
IBD 50: Akorn Aims For $1 Billion In Sales 5:35 p.m. Sept. 19, 2014 - Investors Business Daily
IBD 50 Stocks Setting Up, Including These 5 Medicals 5:35 p.m. Sept. 19, 2014 - Investors Business Daily
Impax Rytary FDA Action Date Extended by Three Months - Analyst Blog 4:30 p.m. Sept. 18, 2014 - Zacks.com
Will Drugmaker Akorn Have A Healthy Bounce Up? 11:09 a.m. Sept. 18, 2014 - Investors Business Daily
Stocks with Upgraded Broker Ratings - Screen of the Week 3:57 a.m. Sept. 16, 2014 - Zacks.com
AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog 5:05 p.m. Sept. 12, 2014 - Zacks.com
5 Top Stocks With Rising Earnings Estimates 7:02 a.m. Sept. 12, 2014 - Investors Business Daily
Wall Street Breakfast: EU Places New Sanctions On Russia, U.S. To Follow 6:32 a.m. Sept. 12, 2014 - Seeking Alpha
Akorn In Second Test Of 10-Week Line 5:09 p.m. Sept. 11, 2014 - Investors Business Daily
Akorn reportedly eyeing tax inversion deal 4:07 p.m. Sept. 11, 2014 - Seeking Alpha
Actavis' Bystolic Combination Gets Negative FDA Panel Vote - Analyst Blog 4:45 p.m. Sept. 10, 2014 - Zacks.com
10 Stocks with 5-Year Returns of 1,500%-Plus 5:10 a.m. Sept. 10, 2014 - InvestorPlace.com
Actavis' Antibiotic under FDA Review, Response in 1Q15 - Analyst Blog 5:20 p.m. Sept. 8, 2014 - Zacks.com
Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog 5:05 p.m. Sept. 5, 2014 - Zacks.com
Salix, Gilead Among 5 Top Medical Leaders To Watch 4:06 p.m. Sept. 5, 2014 - Investors Business Daily

Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 9:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn 8:30 a.m. Sept. 5, 2014 - PR Newswire - PRF
Akorn Completes Acquisition of VersaPharm 8:51 a.m. Aug. 12, 2014 - GlobeNewswire
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed 9:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Akorn Reports Preliminary 2014 Second Quarter Results 6:05 a.m. Aug. 5, 2014 - GlobeNewswire
Global Parkinson%s Disease Market 2014-2018 6:42 p.m. July 28, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information 11:34 a.m. July 15, 2014 - GlobeNewswire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 6:50 a.m. July 2, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
Akorn Divests ECR Pharmaceuticals to Valeant 11:11 a.m. June 20, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Names Craig R. Skenes as Vice President, Business Development 4:05 p.m. June 16, 2014 - BusinessWire - BZX
Pharma Stocks Review -- Research on Akorn, Questcor Pharma, Nektar Therapeutics, and Endocyte 8:00 a.m. June 5, 2014 - PR Newswire - PRF
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn 11:30 a.m. May 9, 2014 - PR Newswire - PRF
Akorn to Acquire VersaPharm for $440 Million 9:19 a.m. May 9, 2014 - BusinessWire - BZX
Akorn Reports 2014 First Quarter Results 7:03 a.m. May 6, 2014 - BusinessWire - BZX
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Actavis to Acquire Four Products from Akorn 4:15 p.m. April 17, 2014 - PR Newswire - PRF
Akorn Completes Acquisition of Hi-Tech Pharmacal 9:21 a.m. April 17, 2014 - BusinessWire - BZX
Repligen Corporation Set to Join the S&P SmallCap 600 5:53 p.m. April 15, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Merit Advisors Shines as Top Energy Workplace

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Rare Collectibles Highlight Morphy's Auction on Oct 4

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Mobile Iron IV Expansions: Targeting Texas Health Needs

Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...

RealNex Navigator Upgrades Unveil Vast CRE Capabilities

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Diaper Affordability: A Hidden Crisis, Taxpayer Burden

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...

Havoc, CSBC Partner for Autonomous Maritime Future

A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...

Liberty Hill: 50 Years of Grassroots Revolution

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

USFCR Wins 2026 Award for Federal Contracting Services

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...